Effects of Different Compression Pressure Levels on Peripheral Circulation After Surgery (COMP-PILOT)

April 5, 2026 updated by: Volkan Gokmen, Agri Ibrahim Cecen University

Evaluation of the Effects of Different Compression Pressure Levels on Lower Extremity Peripheral Circulation in the Postoperative Period: A Pilot Study

After surgery, elastic compression is commonly used on the legs to support blood circulation and reduce the risk of complications such as swelling and venous thromboembolism. In clinical practice, compression is usually applied at fixed pressure levels, although individual patients may respond differently depending on their circulation and tissue tolerance.

The purpose of this pilot study is to evaluate how different compression pressure levels affect peripheral circulation in adult patients during the early postoperative period. Participants will receive three different levels of leg compression applied sequentially under controlled conditions. Peripheral circulation will be assessed using non-invasive methods, including photoplethysmography and peripheral perfusion index measurements.

The findings of this study are expected to provide preliminary evidence on individual circulatory responses to different compression pressures and to support the development of more personalized postoperative compression strategies in future clinical practice.

Study Overview

Detailed Description

Elastic compression therapy is a standard component of postoperative care aimed at improving venous return, reducing lower extremity edema, and supporting peripheral circulation. Despite its widespread use, compression is commonly applied using fixed pressure levels without systematic consideration of individual circulatory responses. This may result in suboptimal effectiveness or discomfort in some patients.

This study is designed as a prospective, single-center pilot interventional study to investigate the effects of different compression pressure levels on lower extremity peripheral circulation in adult postoperative patients. The study will be conducted in surgical wards of Ağrı Training and Research Hospital. Adult patients who have undergone elective surgery and are hemodynamically stable will be enrolled during the early postoperative period.

Each participant will receive three sequential compression pressure levels applied to the calf region using a pressure-controlled compression device. The predefined pressure levels are low (30 mmHg), moderate (45 mmHg), and high (60 mmHg). Compression will be applied in a supine position following a standardized rest period. Each pressure level will be maintained for a fixed duration, with adequate rest intervals between applications to allow circulation to return to baseline.

Peripheral circulation will be assessed at baseline and after each compression level using non-invasive measurement techniques. The primary outcome measures include peripheral perfusion index and venous filling time assessed by photoplethysmography. Secondary outcome measures include lower extremity edema, skin surface temperature, and patient-reported comfort assessed using a visual analog scale. Safety and tolerability will be monitored throughout the study, and compression will be discontinued immediately if any discomfort or adverse effects occur.

As a pilot study, the planned sample size is limited and no formal power calculation has been performed. The primary objective is to generate preliminary data on circulatory responses to different compression pressures and to evaluate the feasibility of the study protocol. The results are intended to inform the design of future larger-scale clinical trials and contribute to evidence-based, individualized postoperative compression practices.

The study will be conducted in accordance with the Declaration of Helsinki. Ethics committee approval was obtained prior to study initiation, and written informed consent will be obtained from all participants before enrollment.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Merkez
      • Ağrı, Merkez, Turkey (Türkiye)
        • Ağrı Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults aged 18 to 65 years
  • Undergoing elective surgery
  • In the early postoperative period at the time of assessment
  • Hemodynamically stable
  • Intact skin on the lower extremities at the planned compression sites
  • Able to understand the study procedures
  • Willing and able to provide written informed consent

Exclusion Criteria:

  • Peripheral arterial disease or clinically significant arterial insufficiency
  • Current or previous diagnosis of deep vein thrombosis or venous thromboembolism
  • Known peripheral neuropathy or sensory impairment affecting the lower extremities
  • Open wounds, active infection, or dermatological conditions on the lower extremities
  • Severe edema requiring therapeutic intervention beyond standard postoperative care
  • Inability to tolerate compression therapy due to pain or discomfort
  • Pregnancy
  • Participation in another interventional clinical study during the same hospitalization period

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sequential Compression Pressure Intervention
All participants will receive sequential lower extremity compression at three predefined pressure levels (30 mmHg, 45 mmHg, and 60 mmHg) applied to the calf region during the early postoperative period, with repeated measurements at each pressure level within the same participant.
A pressure-controlled compression device will be applied to the calf region to deliver sequential compression at three predefined pressure levels: low (30 mmHg), moderate (45 mmHg), and high (60 mmHg). Each pressure level will be applied for a fixed duration with rest periods between applications to allow peripheral circulation to return to baseline. Compression will be performed in the supine position during the early postoperative period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peripheral Perfusion Index (PPI)
Time Frame: Baseline (T0) and during sequential compression applications (T1-T3) within the first 48 hours after surgery

Peripheral Perfusion Index (PPI) will be measured as a dimensionless numerical value using a non-invasive photoplethysmography-based monitoring device. PPI represents the ratio of pulsatile to non-pulsatile blood flow and serves as an objective indicator of peripheral microcirculatory perfusion.

Measurements will be obtained at four predefined time points: baseline before compression (T0), after application of 30 mmHg compression (T1), after application of 45 mmHg compression (T2), and after application of 60 mmHg compression (T3). All measurements will be performed in the supine position following a standardized rest period of at least 10 minutes.

Baseline (T0) and during sequential compression applications (T1-T3) within the first 48 hours after surgery
Venous Filling Time Measured by Photoplethysmography (seconds)
Time Frame: Baseline (T0) and during sequential compression applications (T1-T3) within the first 48 hours after surgery

Venous filling time will be measured in seconds (s) using non-invasive photoplethysmography to assess venous hemodynamic response of the lower extremity. Venous filling time reflects the rate of venous refilling following compression release.

Measurements will be recorded at baseline (T0) and after each compression pressure level: 30 mmHg (T1), 45 mmHg (T2), and 60 mmHg (T3), using standardized sensor placement at the calf region in the supine position.

.

Baseline (T0) and during sequential compression applications (T1-T3) within the first 48 hours after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lower Extremity Edema (Circumference Measurement, cm)
Time Frame: Baseline (T0) and during sequential compression applications (T1-T3) within the first 48 hours after surgery
Lower extremity edema will be assessed by circumferential tape measurements (centimeters) at standardized anatomical landmarks, including the ankle (malleolar level) and calf (maximum circumference), at baseline and after each compression pressure level.
Baseline (T0) and during sequential compression applications (T1-T3) within the first 48 hours after surgery
Skin Surface Temperature (°C)
Time Frame: Baseline (T0) and during sequential compression applications (T1-T3) within the first 48 hours after surgery
Skin surface temperature of the lower extremity will be measured in degrees Celsius (°C) using non-invasive thermal sensors to assess peripheral thermal response associated with different compression pressure levels.
Baseline (T0) and during sequential compression applications (T1-T3) within the first 48 hours after surgery
Patient Comfort Assessed by Visual Analog Scale (VAS, 0-10)
Time Frame: Baseline (T0) and during sequential compression applications (T1-T3) within the first 48 hours after surgery
Patient comfort and tolerance will be assessed using a Visual Analog Scale (VAS) ranging from 0 (no discomfort) to 10 (maximum discomfort). The VAS score will be recorded after each compression pressure level to evaluate subjective comfort during the intervention.
Baseline (T0) and during sequential compression applications (T1-T3) within the first 48 hours after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2026

Primary Completion (Actual)

April 1, 2026

Study Completion (Actual)

April 5, 2026

Study Registration Dates

First Submitted

January 31, 2026

First Submitted That Met QC Criteria

January 31, 2026

First Posted (Actual)

February 6, 2026

Study Record Updates

Last Update Posted (Actual)

April 9, 2026

Last Update Submitted That Met QC Criteria

April 5, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be shared due to the pilot nature of the study, the small sample size, and the single-center design. The collected data include detailed physiological measurements that could potentially increase the risk of participant re-identification. Aggregate and de-identified results will be reported in scientific publications in accordance with ethical approval and data protection regulations.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peripheral Vascular Diseases

Clinical Trials on Pressure-Controlled Compression Device

Subscribe